Citation Impact
Citing Papers
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
2013
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
2017
Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
2014
Tumor-associated macrophages: from basic research to clinical application
2017
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Osteoclasts: more than ‘bone eaters’
2014
Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer
2018
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
2022
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy
2017
ROS in cancer therapy: the bright side of the moon
2020 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Pharmacological targeting of endoplasmic reticulum stress in disease
2021
Deciphering and Reversing Tumor Immune Suppression
2013
The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process
2018
Hallmarks of aging: An expanding universe
2023 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Trial watch
2013
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Therapeutic potential of adult bone marrow‐derived mesenchymal stem cells in diseases of the skeleton
2010
To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response
2019
Emerging Biological Principles of Metastasis
2017 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Carcinoma-associated fibroblasts provide operational flexibility in metastasis
2014
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Targeting metastasis
2016
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Recent advances in bone tissue engineering scaffolds
2012 Standout
The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
2011
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Targeting tumor–stromal interactions in bone metastasis
2013
The IL-6 feed-forward loop: A driver of tumorigenesis
2014
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Immune cell promotion of metastasis
2015
Metastasis Organotropism: Redefining the Congenial Soil
2019
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
2017
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
2015
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
2013 Nature
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
2014
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
2015
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
Binder jet 3D printing—Process parameters, materials, properties, modeling, and challenges
2020 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Spermidine in health and disease
2018 StandoutScience
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
2019
Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
2015
Down-regulation of PLCγ2–β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer
2013
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Multitasking by the OC Lineage during Bone Infection: Bone Resorption, Immune Modulation, and Microbial Niche
2020
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
2015
Works of Anandi Sawant being referenced
Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
2012
Enhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell Pathways
2013
Therapeutic Potential of Adult Bone Marrow–Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
2009
Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells
2012
Role of plasmacytoid dendritic cells in breast cancer bone dissemination
2013
Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
2013
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
2018
Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages
2016
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
2016
Myeloid-Derived Suppressor Cells as Osteoclast Progenitors: A Novel Target for Controlling Osteolytic Bone Metastasis
2013